Article
Doxycycline for Macrolide-Resistant<em> Mycoplasma pneumoniae</em> Pneumonia in Children: Analysis of Efficacy and Safety Across Different Age Groups
2025-10-13
Abstract excerpt
[Objective]: The objective is to assess the effectiveness and safety of doxycycline for treating macrolide-resistant Mycoplasma pneumoniae pneumonia (MRMPP) in pediatric patients across various age ranges, and to explore the value of early switching to doxycycline therapy in children aged <8 years. [Methods] This retrospective cohort study included children diagnosed with MRMPP due to mutations in the 23S rRNA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 69c6dc57-c94a-57a2-9df1-e6885106f15e
- DOI
- 10.20944/preprints202510.0832.v1
